Clinical Trial Update: Perioperative Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating perioperative imatinib mesylate for locally advanced gastrointestinal stromal tumor in patients. The study status is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor

Drugs mentioned

• Gleevec (Imatinib)

Snippet

Sponsor: Peking University | Conditions: Gastrointestinal Stromal Tumor | Phase 2 | Status: COMPLETED